INmune Bio

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell INmune Bio and other ETFs, options, and stocks.

About INMB

INmune Bio, Inc. is a clinical stage biotechnology company, which engages in developing new immunotherapies that reprogram the immune system to fight cancer and Alzheimer’s disease. Its product pipeline includes INKMUNE-Cancer, INB03-Cancer, XPRO1595-Alzheimer and TRD, and LIVNate.

CEO

Raymond J. Tesi

CEORaymond J. Tesi

Employees

Employees22

Headquarters

Boca Raton, Florida

HeadquartersBoca Raton, Florida

Founded

2015

Founded2015

Employees

Employees22

INMB Key Statistics

Market cap

64.60M

Market cap64.60M

Price-Earnings ratio

-1.15

Price-Earnings ratio-1.15

Dividend yield

—

Dividend yield—

Average volume

2.21M

Average volume2.21M

High today

$2.48

High today$2.48

Low today

$2.21

Low today$2.21

Open price

$2.27

Open price$2.27

Volume

1.98M

Volume1.98M

52 Week high

$11.64

52 Week high$11.64

52 Week low

$1.89

52 Week low$1.89

Analyst ratings

43%

of 7 ratings

Buy

42.9%

Hold

42.9%

Sell

14.3%

People also own

Based on the portfolios of people who own INMB. This list is generated using Robinhood data, and it’s not a recommendation.